Novonix Ltd. buy krebskrebs
Start price
22.02.21
/
50%
€2.42
Target price
22.02.22
€3.00
Performance (%)
39.59%
End price
23.02.22
€3.38
Summary
This prediction ended on 23.02.22 with a price of €3.38. The BUY prediction by krebskrebs for Novonix Ltd. saw massive gains of 39.59%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novonix Ltd. | - | - | - | - |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% | 68.627% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% | 116.238% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% | 56.217% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% | 70.924% |
Comments by krebskrebs for this prediction
In the thread Novonix Ltd. diskutieren
Buy mit Kursziel 3,0
In the thread Trading Novonix Ltd.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

